199 related articles for article (PubMed ID: 10460876)
1. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
[TBL] [Abstract][Full Text] [Related]
2. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
Wang HF; Li L; Su HB; Ji W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005
[TBL] [Abstract][Full Text] [Related]
4. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
7. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
9. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
León P; Pozo F; Echevarría JM
Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
[TBL] [Abstract][Full Text] [Related]
10. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
11. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Tang S; Ho SK; Moniri K; Lai KN; Chan TM
Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
[TBL] [Abstract][Full Text] [Related]
14. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
[TBL] [Abstract][Full Text] [Related]
17. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
[TBL] [Abstract][Full Text] [Related]
18. Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
Freiman JS; McCaughan GW
J Gastroenterol Hepatol; 2000 Mar; 15(3):227-9. PubMed ID: 10764020
[No Abstract] [Full Text] [Related]
19. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
20. Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.
Protzer U; Goergen B; Hopf U; Neuhaus P; König V; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1996 Oct; 50(2):135-44. PubMed ID: 8915879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
